168 related articles for article (PubMed ID: 37974899)
1. Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus.
Rabelo VW; da Silva VD; Sanchez Nuñez ML; Dos Santos Corrêa Amorim L; Buarque CD; Kuhn RJ; Abreu PA; Nunes de Palmer Paixão IC
Future Virol; 2023 Sep; 18(13):865-880. PubMed ID: 37974899
[TBL] [Abstract][Full Text] [Related]
2. Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.
Ruiz UEA; Santos IA; Grosche VR; Fernandes RS; de Godoy AS; Torres JDA; Freire MCLC; Mesquita NCMR; Guevara-Vega M; Nicolau-Junior N; Sabino-Silva R; Mineo TWP; Oliva G; Jardim ACG
Virus Res; 2023 Jan; 324():199029. PubMed ID: 36565816
[TBL] [Abstract][Full Text] [Related]
3. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
Dutta SK; Sengupta S; Tripathi A
In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
[TBL] [Abstract][Full Text] [Related]
4. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.
Feibelman KM; Fuller BP; Li L; LaBarbera DV; Geiss BJ
Antiviral Res; 2018 Jun; 154():124-131. PubMed ID: 29680670
[TBL] [Abstract][Full Text] [Related]
5. Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under invitro conditions.
Hasan A; Devi Ms S; Sharma G; Narayanan V; Sathiyarajeswaran P; Vinayak S; Sunil S
J Ethnopharmacol; 2023 Feb; 302(Pt A):115762. PubMed ID: 36181982
[TBL] [Abstract][Full Text] [Related]
6. Organometallic Complex Strongly Impairs Chikungunya Virus Entry to the Host Cells.
de Oliveira DM; Santos IA; Martins DOS; Gonçalves YG; Cardoso-Sousa L; Sabino-Silva R; Von Poelhsitz G; Franca EF; Nicolau-Junior N; Pacca CC; Merits A; Harris M; Jardim ACG
Front Microbiol; 2020; 11():608924. PubMed ID: 33384677
[TBL] [Abstract][Full Text] [Related]
7. 6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.
Kovacikova K; Morren BM; Tas A; Albulescu IC; van Rijswijk R; Jarhad DB; Shin YS; Jang MH; Kim G; Lee HW; Jeong LS; Snijder EJ; van Hemert MJ
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964798
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.
Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S
Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
[TBL] [Abstract][Full Text] [Related]
10. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
[TBL] [Abstract][Full Text] [Related]
11. Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication.
Lam S; Chen KC; Ng MM; Chu JJ
PLoS One; 2012; 7(10):e46396. PubMed ID: 23056297
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
[TBL] [Abstract][Full Text] [Related]
13. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines.
Monsalve-Escudero LM; Loaiza-Cano V; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
BMC Complement Med Ther; 2021 Aug; 21(1):216. PubMed ID: 34454481
[TBL] [Abstract][Full Text] [Related]
14. In Silico Drug Repurposing Uncovered the Antiviral Potential of the Antiparasitic Drug Oxibendazole Against the Chikungunya Virus.
Rabelo VW; Sanchez-Nuñez ML; Corrêa-Amorim LS; Kuhn RJ; Abreu PA; Paixão ICNP
ACS Omega; 2024 Jun; 9(25):27632-27642. PubMed ID: 38947813
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of silymarin against chikungunya virus.
Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
[TBL] [Abstract][Full Text] [Related]
17. Repurposing potential of rimantadine hydrochloride and development of a promising platinum(II)-rimantadine metallodrug for the treatment of Chikungunya virus infection.
Santos IA; Pereira AKDS; Guevara-Vega M; de Paiva REF; Sabino-Silva R; Bergamini FRG; Corbi PP; Jardim ACG
Acta Trop; 2022 Mar; 227():106300. PubMed ID: 34979144
[TBL] [Abstract][Full Text] [Related]
18. The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro.
Ayusso GM; da Silva Sanches PR; Carvalho T; Santos IA; Martins DOS; Lima MLD; da Conceição PJP; Bittar C; Merits A; Cilli EM; Jardim ACG; Rahal P; Calmon MF
Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895860
[TBL] [Abstract][Full Text] [Related]
19. Protective Effects of Caffeine on Chikungunya and Zika Virus Infections: An in Vitro and in Silico Study.
de Jesús López Medina Y; Tamayo-Molina YS; Valdés-López JF; Urcuqui-Inchima S
Chem Biodivers; 2023 Aug; 20(8):e202300192. PubMed ID: 37489706
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
